|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0468 SEK | +1.30% |
|
+11.43% | +1.74% |
Eurocine Vaccines AB (publ) reported earnings results for the first quarter ended September 30, 2023. For the first quarter, the company reported net loss was SEK 2.02 million compared to SEK 5.88 million a year ago. Basic loss per share from continuing operations was SEK 0.039 compared to SEK 0.339 a year ago.
Diluted loss per share from continuing operations was SEK 0.039 compared to SEK 0.339 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +1.74% | 828K | |
| +64.23% | 55.07B | |
| -2.31% | 41.79B | |
| +44.36% | 40.22B | |
| -8.29% | 28.17B | |
| +11.97% | 26.28B | |
| -21.16% | 18.93B | |
| +7.54% | 13.03B | |
| +27.17% | 12.26B | |
| +25.72% | 12.21B |
EUROCINE VACCINES AB 
